RU2017142710A - Состав полиинозиновой-полицитидиловой кислоты (поли-(i:с)) на основе горохового крахмала для профилактики и/или лечения инфекций верхних дыхательных путей - Google Patents

Состав полиинозиновой-полицитидиловой кислоты (поли-(i:с)) на основе горохового крахмала для профилактики и/или лечения инфекций верхних дыхательных путей Download PDF

Info

Publication number
RU2017142710A
RU2017142710A RU2017142710A RU2017142710A RU2017142710A RU 2017142710 A RU2017142710 A RU 2017142710A RU 2017142710 A RU2017142710 A RU 2017142710A RU 2017142710 A RU2017142710 A RU 2017142710A RU 2017142710 A RU2017142710 A RU 2017142710A
Authority
RU
Russia
Prior art keywords
composition
microparticle
starch
microparticles
patient
Prior art date
Application number
RU2017142710A
Other languages
English (en)
Russian (ru)
Inventor
ДЕЙК Алекс Хенри ВАН
Юрген МЕНС
Original Assignee
Янссен Сайенсиз Айрлэнд Юси
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Сайенсиз Айрлэнд Юси filed Critical Янссен Сайенсиз Айрлэнд Юси
Publication of RU2017142710A publication Critical patent/RU2017142710A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2017142710A 2015-05-11 2016-05-10 Состав полиинозиновой-полицитидиловой кислоты (поли-(i:с)) на основе горохового крахмала для профилактики и/или лечения инфекций верхних дыхательных путей RU2017142710A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15167129.4 2015-05-11
EP15167129 2015-05-11
PCT/IB2016/000890 WO2016181226A1 (en) 2015-05-11 2016-05-10 Polyinosinic-polycytidylic acid (poly(i:c)) pea starch formulation for the prevention and/or treatment of upper respiratory tract infections

Publications (1)

Publication Number Publication Date
RU2017142710A true RU2017142710A (ru) 2019-06-11

Family

ID=53174864

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017142710A RU2017142710A (ru) 2015-05-11 2016-05-10 Состав полиинозиновой-полицитидиловой кислоты (поли-(i:с)) на основе горохового крахмала для профилактики и/или лечения инфекций верхних дыхательных путей

Country Status (12)

Country Link
US (1) US20180353533A1 (enExample)
EP (1) EP3294268A1 (enExample)
JP (1) JP2018515530A (enExample)
KR (1) KR20180004233A (enExample)
CN (1) CN107820423A (enExample)
AU (1) AU2016259869A1 (enExample)
CA (1) CA2983659A1 (enExample)
HK (1) HK1251926A1 (enExample)
MA (1) MA44384A (enExample)
RU (1) RU2017142710A (enExample)
TW (1) TW201705963A (enExample)
WO (1) WO2016181226A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824896A4 (en) * 2018-07-20 2022-08-24 Shiseido Company, Ltd. VIRUS INACTIVATION AGENT
CU20200110A7 (es) * 2020-12-23 2022-08-09 Ct Ingenieria Genetica Biotecnologia Péptidos para el tratamiento de infecciones respiratorias de origen viral
KR102451861B1 (ko) 2021-03-09 2022-10-07 주식회사 오라팜 급성 호흡기 바이러스 및 로타바이러스 감염 질환 예방 및 치료를 위한 조성물
KR102439760B1 (ko) 2021-03-09 2022-09-02 주식회사 오라팜 상기도 감염균 질환 예방 및 치료를 위한 조성물
CN114917242A (zh) * 2022-05-31 2022-08-19 复旦大学附属中山医院 合成双链rna类似物经滴鼻预防呼吸道传播病毒的应用及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
CN101229378A (zh) * 2005-05-05 2008-07-30 国家淀粉及化学投资控股公司 用于送递活性剂的组合物
JP2009209086A (ja) * 2008-03-04 2009-09-17 Masami Moriyama 粘膜投与型ワクチン
CN101757018A (zh) * 2008-12-24 2010-06-30 天津瑞普生物技术股份有限公司 一种用于畜禽的聚肌胞干粉及其制备方法
CN102988303A (zh) * 2011-09-15 2013-03-27 天津泽世德生物医药有限公司 一种多聚肌苷酸多聚胞苷酸冻干粉针的制备方法
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
TWI643082B (zh) * 2013-09-03 2018-12-01 美商新思科技股份有限公司 一種佈線出一解決路徑之方法及系統
KR20160072140A (ko) * 2013-11-06 2016-06-22 얀센 사이언시즈 아일랜드 유씨 상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형

Also Published As

Publication number Publication date
MA44384A (fr) 2019-01-23
KR20180004233A (ko) 2018-01-10
HK1251926A1 (zh) 2019-05-03
US20180353533A1 (en) 2018-12-13
WO2016181226A1 (en) 2016-11-17
CN107820423A (zh) 2018-03-20
CA2983659A1 (en) 2016-11-17
EP3294268A1 (en) 2018-03-21
TW201705963A (zh) 2017-02-16
JP2018515530A (ja) 2018-06-14
AU2016259869A1 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
RU2016117398A (ru) Композиции полиинозиновой-полицитидиловой кислоты (поли (и:ц)) для лечения инфекций верхних дыхательных путей
Pham et al. Strategies for the design of orally bioavailable antileishmanial treatments
JP2016535094A5 (enExample)
JP2015515968A5 (enExample)
CR20210368A (es) Combinación de dextrometorfano y bupropión para el tratamiento de depresión
JP2014240439A5 (enExample)
JP2005527535A5 (enExample)
Jiang et al. Toward the prevention of coronavirus infection: what role can polymers play?
JP2010511596A5 (enExample)
BR112015011778A2 (pt) métodos para administrar e avaliar drogas de expulsão de nitrogênio para o tratamento de encefalopatia hepática
JP2019519570A5 (enExample)
BR112014026957A8 (pt) micropartícula, composição compreendendo a mesma, seu uso e sistema de distribuição nasal relacionados ao tratamento de infecções do trato respiratório superior
JP2017512194A5 (enExample)
JP2017507142A5 (enExample)
JP2018515530A5 (enExample)
CN102166219A (zh) 一种鼻腔给药制剂及其应用
CN104628657A (zh) 一类治疗缺血性脑损伤的化合物及其用途
FI3352735T3 (fi) Pitkitetysti vapauttavia olantsapiiniformulaatioita
WO2014075203A1 (es) Nanopartículas con polímero biodegradable y biocompatible plga cargadas con el fármaco de uso humano pentoxfilina
JP2016534078A5 (enExample)
Schroeder et al. Advancing influenza virus treatment: in vitro and ex vivo studies of PI3K inhibitor-loaded lipid nanoparticles
ES2894330T3 (es) Acido acetilsalicílico para uso en el tratamiento de la influenza de moderada a grave
RU2012116226A (ru) Бронхолитическое средство на основе простагландина
Garg et al. Nanomedicine: emerging trends in treatment of malaria
JP2019510731A5 (enExample)

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20201208